Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Oxidopamine hydrobromide

Cat. No.: IBDI-438059

Oxidopamine (6-OHDA) hydrobromide is an antagonist of the neurotransmitter dopamine. Oxidopamine hydrobromide is a widely used neurotoxin and selectively destroys dopaminergic neurons. Oxidopamine hydrobromide promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion. Oxidopamine hydrobromide can be used for the research of Parkinson’s disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome.

Size (Solid):

Product Details

Target Dopamine Receptor | Autophagy | Mitophagy | COX | PGE synthase | Interleukin Related | p38 MAPK | Apoptosis | Caspase
Molecular Weight 250.09
Appearance Solid
Synonyms 6-Hydroxydopamine hydrobromide, 6-OHDA hydrobromide
SMILES OC1=CC(CCN)=C(O)C=C1O.[H]Br
Purity 99.95%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.